Author:
Swetter Susan M.,Carroll Lisa A.,Johnson Denise L.,Segall George M.
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Gritters LS, Francis IR, Zasadny KR, Wahl RL. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-d-glucose in the imaging of malignant melanoma.J Nucl Med 1993;34:1420–7.
2. Steinert HC, Huch-Böni RA, Buck, A, et al. Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-d-glucose.Radiology 1995;195:705–9.
3. Böni R, Huch-Böni RA, Steinert H, von Schulthess GK, Burg G. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-d-glucose.Br J Dermatol 1995;132:556–62.
4. Macfarlane DJ, Sondak V, Johnson T, Wahl RL. Prospective evaluation of 2-[18F]-2-deoxy-d-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.J Clin Oncol 1998;16:1770–6.
5. Rinne D, Baum RP, Hör G, Kaufmann R. Primary staging and follow-up of high risk melanoma patients with whole-body18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients.Cancer 1998;82:1664–71.
Cited by
107 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献